Martingale Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,520
| Closed | -$510K | – | 768 |
|
|
2024
Q4 | $510K | Sell |
15,520
-19,773
| -56% | -$650K | 0.01% | 603 |
|
|
2024
Q3 | $1.57M | Hold |
35,293
| – | – | 0.04% | 368 |
|
|
2024
Q2 | $1.52M | Sell |
35,293
-10,114
| -22% | -$436K | 0.03% | 359 |
|
|
2024
Q1 | $1.33M | Buy |
45,407
+2,097
| +5% | +$61.3K | 0.03% | 397 |
|
|
2023
Q4 | $965K | Buy |
43,310
+181
| +0.4% | +$4.03K | 0.02% | 457 |
|
|
2023
Q3 | $1.07M | Sell |
43,129
-2,291
| -5% | -$56.7K | 0.02% | 417 |
|
|
2023
Q2 | $1.29M | Buy |
45,420
+19,341
| +74% | +$548K | 0.03% | 377 |
|
|
2023
Q1 | $599K | Buy |
+26,079
| New | +$599K | 0.01% | 572 |
|
|
2021
Q4 | – | Sell |
-12,203
| Closed | -$564K | – | 819 |
|
|
2021
Q3 | $564K | Buy |
12,203
+4,999
| +69% | +$231K | 0.01% | 646 |
|
|
2021
Q2 | $398K | Buy |
+7,204
| New | +$398K | ﹤0.01% | 662 |
|